Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Author Index

Author Index ATLA 36, 731–745, 2008 731 Volume 36 (1–6) not including Supplement 1 Adler, S. et al. (2008). Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells. Article 36 (2), 129–140. Ahmed, S.U. see Das, H. et al. (2008). β-Defensin antibiotic peptides in the innate immunity of the buffalo: in vivo and in vitro studies. Article 36 (4), 429–440. Ahr, H-J. et al. (2008). Barriers to validation. Article 36 (4), 459–464. Aleksic, M. see Gerberick, G.F. et al. (2008). Chemical reactivity measurement and the predictive identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Article 36 (2), 215–242. see Maxwell, G. et al. (2008). Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation. Article 36 (5), 557–568. Alepée, N. see Bottini, A.A. et al. (2008). Optimisation of the post-validation process. The report and recommendations of ECVAM Workshop 67. Article 36 (3), 353–366. see Ahr, H-J. et al. (2008). Barriers to validation. Article 36 (4), 459–464. Alves, E.N. et al. (2008). A reassessment of the in vitro RBC haemolysis assay with defibrinated sheep blood for the determination of the ocular irritation potential of cosmetic products: comparison with the in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alternatives to Laboratory Animals SAGE

Author Index

Alternatives to Laboratory Animals , Volume 36 (6): 15 – Dec 1, 2008

Loading next page...
 
/lp/sage/author-index-Um7Qria89k

References (37)

Publisher
SAGE
Copyright
© 2008 Fund for the Replacement of Animals in Medical Experiments
ISSN
0261-1929
eISSN
2632-3559
DOI
10.1177/026119290803600621
Publisher site
See Article on Publisher Site

Abstract

ATLA 36, 731–745, 2008 731 Volume 36 (1–6) not including Supplement 1 Adler, S. et al. (2008). Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells. Article 36 (2), 129–140. Ahmed, S.U. see Das, H. et al. (2008). β-Defensin antibiotic peptides in the innate immunity of the buffalo: in vivo and in vitro studies. Article 36 (4), 429–440. Ahr, H-J. et al. (2008). Barriers to validation. Article 36 (4), 459–464. Aleksic, M. see Gerberick, G.F. et al. (2008). Chemical reactivity measurement and the predictive identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Article 36 (2), 215–242. see Maxwell, G. et al. (2008). Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation. Article 36 (5), 557–568. Alepée, N. see Bottini, A.A. et al. (2008). Optimisation of the post-validation process. The report and recommendations of ECVAM Workshop 67. Article 36 (3), 353–366. see Ahr, H-J. et al. (2008). Barriers to validation. Article 36 (4), 459–464. Alves, E.N. et al. (2008). A reassessment of the in vitro RBC haemolysis assay with defibrinated sheep blood for the determination of the ocular irritation potential of cosmetic products: comparison with the in

Journal

Alternatives to Laboratory AnimalsSAGE

Published: Dec 1, 2008

There are no references for this article.